Advisory Council January 2021 Meeting Presentation: COVID-19 Vaccine Implementation

01/25/2021

ADVISORY COUNCIL ON ALZHEIMER'S RESEARCH, CARE, AND SERVICES

Monday, January 25, 2021

Printer Friendly Version in PDF Format (9 PDF pages)

 

COVID-19 Vaccine Implementation

Dr. Georgina Peacock
Centers for Disease Control and Prevention

COVID-19 Vaccine Distribution and Initiation
As of January 24, 2021

  • Overall US COVID-19 Vaccine Distribution and Administration
    • Total Doses Distributed 41,411,550
    • Total Doses Administered 21,848,655
    • Number of People Receiving 1 or More Doses 18,502,131
    • Number of People Receiving 2 Doses 3,216,836
    • [CDC, Data as of: Jan 24 2021 6:00am ET; Posted: Jan 24 2021 2:01PM ET]
  • Federal Pharmacy Partnership for Long-Term Care Program (Subset of Overall Numbers)
    • Doses Administered in Long-Term Care Facilities 2,567,018
    • [CDC, Data as of: Jan 24 2021 6:00am ET; Posted: Jan 24 2021 2:01PM ET]
Total Doses Administered Reported to the CDC by State/Territory and for Selected Federal Entities per 100,000
State Map showing doses administered.
Available: https://covid.cdc.gov/covid-data-tracker

COVID-19 Vaccination is a Safer Way to Build Protection

  • Getting the virus that causes COVID-19 may offer some natural protection, known as an antibody or immunity.
    • However, experts don’t know how long this protection lasts.
  • The risk of severe illness and death from COVID-19 far outweighs any benefits of natural immunity.
  • COVID-19 vaccination will help protect you by building immunity without the risk of severe illness.

COVID-19 Vaccines Under FDA Emergency Use Authorizations (EUAs)

Explaining mRNA COVID-19 Vaccines

  • mRNA vaccines take advantage of the process that cells use to make proteins in order to trigger an immune response
    • Like all vaccines, COVID-19 mRNA vaccines have been rigorously tested for safety before being authorized for use in the United States
    • mRNA technology is new, but not unknown. They have been studied for more than a decade
    • mRNA vaccines do not contain a live virus and do not carry a risk of causing disease in the vaccinated person
    • mRNA from the vaccine never enters the nucleus of the cell and does not affect or interact with a person’s DNA

ACIP: COVID-19 Vaccine Guiding Principles

  • Equity
    • Efficient Distribution. During a pandemic, efficient, expeditious and equitable distribution and administration of authorized vaccine is critical
    • Flexibility. Within national guidelines, state and local jurisdictions should have flexibility to administer vaccine based on local epidemiology and demand

Overview of Groups Prioritized by ACIP

Phase 1a Phase 1b Phase 1c Phase 2
  • Health care personnel
  • Long-term care facility residents
  • Frontline essential workers
  • Persons aged 75 years and older
  • Persons aged 65-74 years
  • Persons aged 16-64 years with high-risk conditions
  • Essential workers not recommended in Phase 1b
  • All people aged 16 years and older not in Phase 1, who are recommended for vaccination
Initiation of phases will be overlapping
Four arrows showing the phases overlapping.

Special challenges and considerations for vaccination of older adults

  • Access to information about when they are eligible for vaccination and where they can obtain vaccine
  • Vaccine access for persons living in
    • Congregate settings
    • Adult family homes
    • Rural areas
  • Vaccine access for persons with
    • Cognitive decline
    • Limited family or community support
    • Mobility or disability challenges
    • Limited or no transportation

Key Facts about COVID-19 Vaccinati

*https://www.cdc.gov/coronavirus/2019-ncov/hcp/testing-overview.html

What to expect before, during, and after COVID-19 vaccination

  • Before
    • Learn about COVID-19 vaccines.
    • See if COVID-19 vaccination is recommended for you.
  • During
    • Read the fact sheet that tells you about the specific COVID-19 vaccine you receive.
    • Receive a vaccination record card.
  • After
    • Expect some side effects.
    • Enroll in v-safe. V-safe will remind you if you need a second shot.
    • Continue using all the measures to protect yourself and others.
  • V-safe: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/vsafe.html

Safety of COVID-19 Vaccines is a Top Priority

  • COVID-19 vaccines are being held to the same safety standards as all vaccines.
  • Before Authorization
    • FDA carefully reviews all safety data from clinical trials.
    • ACIP reviews all safety data before recommending use.
  • After Authorization
    • FDA and CDC closely monitor vaccine safety and side effects. There are systems in place that allow CDC and FDA to watch for safety issues.
  • V-safe: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/vsafe.html

Active Safety Monitoring for COVID-19 Vaccines

  • V-safe is a new CDC smart-phone based monitoring program for COVID-19 vaccine safety
    • Uses text messaging and web surveys to check-in with vaccine recipients after vaccination
    • Participants can report any side effects or health problems after COVID-19 vaccination
    • Includes active telephone follow-up by CDC for reports of significant health impact

Vaccination is one measure to help stop the pandemic

  • While COVID-19 mRNA vaccines appear to be highly effective, additional preventive tools remain important to limit the spread of COVID-19.
  • The combination of getting vaccinated and following CDC recommendations to protect yourself and others offers the best protection from COVID-19.
    • Cover your nose and mouth with a mask.
    • Stay at least 6 feet from people who don’t live with you.
    • Avoid crowds and poorly ventilated indoor spaces.
    • Wash your hands.

Protect yourself, your family, friends, coworkers, and your community.

  • Get vaccinated.
    • Choose to get vaccinated when it is offered.
    • Participate in v-safe and help CDC monitor for any health effects after vaccination.
    • Share your experience with coworkers, friends, and family.
    • Know the basics about the COVID-19 vaccine. Help answer questions from your family and friends.
    • Show you received the vaccine by wearing a sticker or button prominently.

Additional information about COVID-19 among older adults

CDC Resources

  • Learn more with CDC’s COVID-19 vaccine tools and resources. Find information for COVID-19 vaccination administration, storage, reporting, patient education, and more.
  • COVID-19 Vaccine Communications Toolkits
    • Medical Centers, Clinics, and Clinicians
    • Long-Term Care Facilities
    • Community Based Organizations
    • Essential Workers

 

Screen shots of CDC resources.

Thank you

The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

For more information, contact CDC
1-800-CDC-INFO (232-4636)
TTY: 1-888-232-6348 https://www.cdc.gov/


Return to

National Alzheimer's Project Act Home Page

Advisory Council on Alzheimer's Research, Care, and Services Page

Advisory Council on Alzheimer's Research, Care, and Services Meetings Page